Skip to main content

Advertisement

Table 3 The incidence of major complications after TIPS treatment

From: Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment

  HE Re-bleeding/Bleeding
Total 267/704 (37.9%) 109/704 (15.5%)
 Variceal bleeding 208/581 (35.8%) 81/581 (13.9%)
 Refractory ascites 31/72 (43.1%) 6/72 (8.3%)
 Variceal bleeding and refractory ascites 28/51 (54.9%) # 22/51 (43.1%) ##
Child-Pugh classification   
 A 83/219 (37.8%) 37/219 (16.9%)
 B 142/421 (33.7%) 61/421 (14.5%)
 C 42/64 (65.6%) ## 11/64 (17.2%)
Type of stent   
 Uncovered stent (n = 130) 56/130 (43.1%) 17/130 (13.1%)
  Diameter of stent = 8 mm (n = 47) 17/47 (36.1%) 5/47 (10.6%)
  Diameter of stent = 10 mm (n = 83) 39/83 (47.0%) 12/83 (14.5%)
 Covered stent (n = 574) 211/574 (36.8%) 92/574 (16.0%)
  Diameter of stent = 6 mm (n = 94) 6/94 (6.4%) ### 14/94 (14.9%)
  Diameter of stent = 7 mm (n = 178) 67/178 (37.6%) 31/178 (17.4%)
  Diameter of stent = 8 mm (n = 302) 138/302 (45.7%) 47/302 (15.6%)
  1. #P < 0.05, ## P < 0.01, and ### P < 0.01 compared with other groups, Chi-squared test